Stay updated with breaking news from Adam Kaseman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA approved the first RSV vaccine Wednesday, called Arexvy, which is designed to be given as a single shot to adults 60 and over.
After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV -- and more are on the way.
After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV -- and more are on the way.
After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV -- and more are on the way.
Arexvy, made by GSK, is designed to be given as a single shot to adults 60 and older.